Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...
Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 ...
Hosted on MSN6m
Novel Drug Eases Disease Activity in DermatomyositisCurrent treatments for dermatomyositis include various immunosuppressants and immunosuppressive agents, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback